AMDL, Inc. Announces First Quarter 2009 Financi...(2008. Selling general and admi...),Health

Selling, general and administrative expenses for the Company were approximately $2.59 million for the quarter ended March 31, 2009 as compared to approximately $2.80 million for the same period in FY2008 due to a reduction in payroll expense and professional fees.

Loss before discontinued operations for the quarter ended March 31, 2009 was $1.9 million, or $0.12 per share compared to the quarter ended March 31, 2008 when the Company's loss before discontinued operations was $1.7 million, or $0.11 per share. As previously announced, AMDL has discontinued operations at its YYB subsidiary and is negotiating the sale of that facility. For the quarter ended March 31, 2009 the Company recognized income of approximately $247,000 from discontinued operations.

"Seasonally the first quarter is consistently our most challenging, and as we communicated in our FY2008 earnings call, we anticipated first quarter results to be slightly lower than the corresponding period last year," commented Mr. Douglas MacLellan, Chairman and Chief Executive Officer of AMDL, Inc. "Downward first quarter sales resulted from the combination of a traditional slower business environment surrounding the Chinese New Year holiday and product sales impact resulting from a non-operational China-based production line and expired distributor contracts."

FY2009 Outlook

AMDL reaffirms the Company is on track with its FY2009 projections and expects to meet its FY2009 financial forecast of estimated gross revenues of US$64 - $72 million and net income between US$8 - $12 million after taxes and before foreign currency translation gains or losses. This represents revenues for the Company's China-based operations only. Additionally, the Company expects to recoup 100% of its forecasted product production levels over the course of the remaining year and anticipates it will carry over approximately $1.4 millio
'/>"/>